Respiratory syncytial virus PFP-1 vaccine - Wyeth
Latest Information Update: 05 Nov 2023
At a glance
- Originator Wyeth
- Class Respiratory syncytial virus vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Respiratory syncytial virus infections
Most Recent Events
- 07 Oct 2002 Phase-II clinical trials in Respiratory syncytial virus infections in USA (Injection)
- 25 Jun 2001 No-Development-Reported for Respiratory syncytial virus infections in USA (Injection)
- 30 Oct 1995 Phase-II clinical trials for Respiratory syncytial virus infections in USA (Injection)